AptarGroup (ATR) stock is drawing fresh attention after two developments hit at once: a new Aptar Pharma president was appointed, and analyst coverage turned more constructive ahead of the upcoming Q3 earnings release.
AptarGroup’s share price has eased over the past quarter, with a 90 day share price return of 4.39% in the red. However, the year to date share price return of 3.27% and a 3 year total shareholder return of 8.22% suggest steadier long term progress despite recent executive changes and shifting earnings expectations.
Compare how AptarGroup stacks up against a hand picked 30 resilient stocks with low risk scores that investors use when searching for resilient ideas ahead of earnings season.
AptarGroup now sits in an awkward middle ground after the recent pullback and analyst upgrade. Is most of the easy move already gone, or does the current valuation still leave meaningful upside on the table?
Most Popular Narrative: 22% Undervalued
AptarGroup’s most followed narrative pegs fair value at $162.00, well above the recent $126.55 close. As a result, the discussion turns to whether the Pharma engine can keep justifying that gap.
Ongoing work to move from component supplier to a more integrated drug delivery and services partner, including formulation, analytical and regulatory support, clinical filling and digital patient tools, increases customer dependence on AptarGroup and can support higher value revenue and more resilient net margins.
See why 7 investors see AptarGroup as 22% undervalued.
Result: Fair Value of $162.00 (UNDERVALUED)
Still, the Pharma story at AptarGroup can be knocked off course if emergency medicine destocking drags on, or if Beauty and Closures margins stay subdued longer than expected.
Find out about the key risks to this AptarGroup narrative.
Another View: AptarGroup Through The P/E Lens
The DCF narrative presents AptarGroup as undervalued, yet the current 22.5x P/E tells a different story. That multiple sits well above both the 17.7x peer average and the 17.5x fair ratio. For investors, that gap highlights valuation risk if sentiment moves away from premium pricing.
See what the numbers indicate about this price in more detail by checking the See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Mixed signals on AptarGroup often create the most interesting set ups, so treat this as your prompt to move fast and pressure test the data yourself. For a clearer picture of how the upside and downside stack up, review the 4 key rewards and 2 important warning signs.
Looking for more AptarGroup style investment ideas?
If you want a stronger watchlist before the next AptarGroup update lands, now is the moment to scan other opportunities with solid fundamentals and clear risk profiles.
- Target steadier compounding by reviewing a 6 dividend fortresses that focuses on income potential backed by firms with sizeable yields and support from current financial metrics.
- Hunt for pricing gaps using a 20 high quality undiscovered gems that surfaces companies with solid fundamentals that many investors have not yet focused on.
- Reduce portfolio stress and tighten downside risk by screening a list of solid balance sheet and fundamentals (26 results) that spotlights businesses with stronger finances and healthier leverage.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com